Compass Therapeutics (CMPX) Enterprise Value (QoQ) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Compass Therapeutics | 418.47 Mn | 223.78 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.06% |
| Dec 31, 2025 | 4.74% |
| Sep 30, 2025 | -116.61% |
| Jun 30, 2025 | 10.32% |
| Mar 31, 2025 | 11.07% |
| Dec 31, 2024 | -7.87% |
| Sep 30, 2024 | 19.30% |
| Jun 30, 2024 | 16.95% |
| Mar 31, 2024 | -15.48% |
| Dec 31, 2023 | 6.87% |
| Sep 30, 2023 | 2.99% |
| Jun 30, 2023 | 3.66% |
| Mar 31, 2023 | 6.11% |
| Dec 31, 2022 | -54.69% |
| Sep 30, 2022 | 8.65% |
| Jun 30, 2022 | 3.21% |
| Mar 31, 2022 | 5.61% |
| Dec 31, 2021 | -466.72% |
| Mar 31, 2021 | 15.68% |
| Dec 31, 2020 | 15.21% |
| Sep 30, 2020 | 15.07% |
| Jun 30, 2020 | -1,745,454.07% |
| Mar 31, 2020 | 99.99% |
| Dec 31, 2019 | -2,868,720.86% |
| Sep 30, 2019 | 81.87% |
| Jun 30, 2019 | 0.00% |
| Mar 31, 2019 | -4.00% |
| Dec 31, 2018 | -91.29% |
| Sep 30, 2018 | 66.17% |